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1 Abstract
We report a microfluidic device able to control the ejection of fluid through a
matrix of out-of-plane microneedles. The device comprises a matrix of open
dispensing units connected to needles and filled by a common filling system.
A deformable membrane (e.g. in PDMS) is brought into contact with the dis-
pensing units. A pressure exerted on the deformable membrane will close (and
thus individualize) each dispensing unit and provoke the ejection of the dispens-
ing unit content through the outlets. A sufficient pressure over the deformable
membrane will ensure that all dispensing units will deliver a fixed volume (their
content) irrespective of the hydrodynamic pressure outside the dispensing unit
outlet. The size of the ensemble matrix of dispensing units, the number of liq-
uid reservoirs, as well as the material can vary depending on the considered
application of the device or on the conditions of use. In the present paper, the
liquid reservoirs are gemetricaly identical. The geometrical parameters of the
device are optimized to avoid as much dead volume as possible, as it was though
to handle plasmid DNA solutions which are very expensive. The conception,
the fabrication and the experimental results are described in the paper. Our
prototype is conceived to inject in a uniform way 10 µl of drug through 100
microneedles distributed over one square centimetre.
2 Introduction
Since a decade of years, matrix of microneedles have been proposed as an in-
novative tool to enhance transdermal drug delivery [1]. A lot of work has been
done to define the geometrical shape of these needles [2, 3, 4]. However, just
a few papers ([5, 6, 7, 8]) deal with the way to connect this objects to a liq-
uid injection/extraction process. Since these needles are dedicated to inject or
extract fluids from the skin, a fluidic system is required to handle the liquids.
The simplest way to inject a liquid through a microneedle matrix is to use a
single reservoir that is emptied through the whole matrix. This type of system
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is presented for example in the works of B. Stoeber [5]. While the liquid should
mainly pass through the needles with the lower hydrodynamic resistance, such
a system should not permit to control the quantity of drug that is injected
through each needle. Indeed, apart from the fact that the needles are hardly
exactly identical, the skin is not a homogeneous material leading to different
hydrodynamic resistance at needle exit, this leads to an inhomogeneous injection
of the drug into the skin. Another limit of this simple way to inject liquid
through microneedles is pointed out by B. Stoeber : the system does not allow
to control precisely the amount of injected drug. Consequently, there are mainly
two bottlenecks to face concerning liquids handling : homogeneous spreading
through the skin and control of the amount of injected liquid.
In this paper, we report a work in which we describe a microfluidic system
that can be connected to a needle matrix, answering to both bottlenecks. This
work has been done in the framework of a research project dedicated to the
gene treatment of skin diseases by means of microneedles (European project
ANGIOSKIN, number LSH-2003-512127). For this kind of treatment, the ther-
apeutical drug has to be equally distributed over the treated skin surface. Fur-
thermore, the DNA solutions used in these treatments are very expensive and
are available only in small quantities. In this context, a distribution system that
was able to both manipulate small quantities of fluid with minimal losses was
mandatory.
Manufacturing microfluidic distribution system is not a technical challenge.
For example, an ink jet printer can provide millions of picoliters ink spot in one
second. For pharmaceutical use, there are also more specific spotters that are
able to manipulate biological fluids such as the VIRTEKs ChipWriterProTM .
However, only few works propose the integration of a fluidic system with a
microneedle matrix. Some works present the adaptation of a microfluidic system
with a single needle [6] or with a row of five needles [7]. But as far as we know,
no work reported the integration of a microfluidic distribution system with a
matrix of out-of-plane microneedles.
We report a simple solution to provide a homogeneous injection through a
microneedle matrix with the control of the injected quantity of drug. The idea
is to adapt a single drug reservoir over each needle, i.e. a single reservoir is split
over as many reservoirs as the number of needles. The reservoirs are covered
by a membrane that can deflect under pressure and chase the drug through the
needle. The dimensions of the reservoir determine the injected volume and the
injection is homogeneous while all the reservoirs are pumped out through each
single needle.
3 System
3.1 Description
The system is composed of individual reservoirs disposed on a matrix way. Fig-
ure 1 shows a top view of the matrix; the chambers are distributed on one square
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Figure 1: Top view of the system
Figure 2: The microfluidic distribution system stuck on an hollowed silicon
matrix
centimetre. They are connected to each other via a network of microchannels in
order to allow the filling of the whole system from a single sample of product.
From the entry to the exit, the filling circuit is composed of five part (Figure
1) : (i) the inflow reservoir, the drug is brought at the entry of each chamber
row (this part is connected to the atmospheric pressure), (ii) the chamber ma-
trix connected by small channels (filling circuit), (iii) hydrodynamic resistances
which are added in order to obtain a homogenous filling of the system (details
are given below), (iv) the outflow reservoir which is only used to connect all the
channels to a single exit, and (v) a fluidic diode placed at the connection be-
tween the outflow and the pressure reservoir (contained into a box). The diode
at the end prevents the drug to flow back through the filling circuit during the
injection, i.e., while the pressure is increased into the box in order to deflect the
membrane used to chase the liquid reservoir content throught its counterpart
needle.
The reservoirs and the filling circuit are covered by a hyperelastic membrane.
The mechanical properties of the membrane are chosen to achieve very high
deformations in order to pump out a maximum of the chambers content through
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the needles when it is under pressure. Figure 2 is a picture of the microfluidic
system stuck on a silicon needle matrix.
Figure 3 is a transversal sketch of the system presenting the way our system
is able to both fill the dispensing units from a single entrance as well as eject
the content of each dispensing units through the corresponding needles. The
details of the principle are given in next section.
3.2 Principle
Figure 3: Left : filling of the system, right : ejection of the drug
The system is filled from a single drop of drug. Its volume is the one of
the total system volume. The drop is brought at the entry of the filling circuit
by hand. In order to prevent any leak from the chambers to the outlet of the
needles, the needles are driven into a soft material in order to close them while
filling the chambers matrix (Figure 3, left). The drug drop is then sucked into
the chamber matrix by means of a reduction of the pressure into the box which
is connected to the exit of the filling circuit. During this stage, the fluidic diode
is open.
Figure 4: Filling circuit cross section
The filling circuit is located just under the membrane. Figure 4 presents
a cross section of it. During filling, the membrane deflects upwards and the
hydrodynamic resistance of the filling circuit is very low (case 1 in figure 4).
When the pressure inside the box is reversed for the ejection of the fluid, the
membrane deflects downwards and the section of the channels is dramatically
reduced (case 2 in figure 4). This conducts to a very high hydrodynamic re-
sistance in the channel which prevents the drug to use this pathway preferably
to the needle one. This geometry assures that the system behaves like a fluidic
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circuit during the filling and like a matrix of individual chambers during the
ejection, which is one of the core of the system.
For the ejection, the soft material which closes the needles is removed and
the pressure in the box is increased (Figure 3, right). This closes the fluidic
diode, makes the chambers individual units, and while the membrane deflects
into the chambers it ejects the drug through the needles.
It is a single use system. In one hand, for hygienic reasons, the system
cannot be used twice without been sterilized, and in the other hand, after a first
use, some drug remains into the system and prevents a good filling of it. It is
however possible to rinse it with water and let it dry up before a new use.
3.3 Fabrication
Figure 5: (A) Mould realization by SU8 photolithography, (B) Backing into
a press system, (C) Gluing on the membrane using an oxygen plasma, (D)
Removal and cutting of the system, (E) Gluing on the microneedle matrix using
an oxygen plasma, (F) Packaging
To manufacture the system, we first made a mould for both the chamber
matrix and the filling circuit. The soft photolithography technology with a
thick photoresist (SU8) was used. In a first step the wafer is coated with a
100 µm photoresist layer and is further insulated to make the filling circuit;
then a second layer of 200 µm or more is coated over the first layer to make
the chambers. To obtain a photoresist layer as thick as 200 µm, SU82100 is
spincoated and baked several times. Each spincoating adds a layer about 100
µm thick.
The mould is then developed and CHF3 is deposited on it by a plasma
treatment. This treatment makes the removal of PDMS easier after casting.
More than two steps of photoresist coating and insulation can be processed in
order to achieve a pyramidal structure. A pyramidal structure assures a better
sealing of the filling circuit (figure 4) and reduces the dead volume (i.e. liquid
that is lost) into the chambers after injection. Usually, the filling circuit is
realised in two steps and the chambers in three.
5
Figure 5 describes the different manufacturing steps. First, the commercially
PDMS prepolymer and catalyser (RTV 615, Bayer silicones) are mixed and
deposited on the mould. The PDMS is then degased under vacuum to eliminate
bubbles created during preparation. To make the chambers pierce the PDMS
sheet, the mould is put into a pressing system during backing. In parallel, the
membrane is made by speencoating PDMS on a clean wafer. At a speed of
2200 tr/min during thirty seconds, we can realize a thirty micrometer thick
membrane. The membrane is then glued on the chambers after being activated
by oxygen plasma.
The fluidic diode is made at this stage. A square of thin paper is put on the
system at the place of the diode to prevent the gluing of the membrane. The
trap is then cut off with a cutter and the paper is removed.
Lastly, the PDMS system is glued on the microneedles matrix using again
an oxygen plasma activation and the whole system is packed into a box that
can be connected to a pressure system. During assembling, care is done in
order to leave the fluid inlet outside the box, while all the microfluidic system is
contained into the box (filling circuit, matrix chamber, fluid outlet and fluidic
diode).
4 Study
4.1 Material
The material used for the system is PDMS. This polymer is easily mouldable
at the microscale and has hyperelastic properties. The mechanical properties of
this material are very variable. Specifically the shear modulus, which determines
the propensity of the membrane to deflect, can vary from 100 kPa to 3 MPa [9].
These mechanical properties depend on several factors such as the proportion
of mixed prepolymer and catalyser, the time and temperature into the oven or
the brand of the PDMS that is used.
To allow the membrane to have the maximal deformation, we need a low
shear modulus. This modulus was measured using traction assays. For a mix-
ture of 15 volumes prepolymer for 1 volume catalyser, a shear modulus of 250
kPa (baking 2h at 70 C, brand RTV) was measured. For a 10:1 mixture with
the same other parameters, the shear modulus was about 400 kPa. With this
in mind, we realized the membrane of the system with a 15:1 mixture and the
chambers with a 10:1 mixture. Different catalyser ratio helps the gluing of the
membrane on the chambers.
The PDMS is naturaly a hydrophobic material. However some treatments
such as the oxygen plasma activation make it temporaly hydrophilic. It is
therefore possible to choose the surface properties of the PDMS (hydrophilic vs
hydrophobic).
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4.2 Filling system
The filling circuit is designed to fill entirely all the chambers of the matrix. There
are two main difficulties with this part : bubbles may stay inside the chambers
and some chambers may not be filled at all due to small local inhomogeneity of
the material.
To prevent the formation of bubbles inside the chambers during the filling,
the walls have to be hydrophobic. With hydrophilic walls, the filling circuit is
instantaneously filled by capillarity without any pressure. But the capillarity
does not fill the whole chambers, and these bubbles cannot be chased out of the
system. With hydrophobic walls, the drug firstly fills completely the chambers
before going further into the filling circuit in which the ratio surface/bulk is
higher.
While the walls are hydrophobic, when a row of chambers is completely filled
until the exit of the filling circuit, the drug will stop to fill the remaining empty
chambers. The entire drug will pass through the way already achieved. For
this reason, all the chambers must be filled before the drug reaches the exit.
However, practically, all the rows of chambers are not filled at the same speed.
This is probably due to small local inhomogeneities in the materials properties.
To assure the complete filling of the matrix, hydrodynamic resistances are added
at the end of the filling circuit. Since the liquid has more affinity to fill lower
surface/ratio parts, the drug starts to fill the hydrodynamic resistances when
all the chambers are filled.
4.3 System sizing
Figure 6: Cross section of the chambers during injection. Left without a pyra-
midal structure and right the pyramidal structure reduces the dead volume
Sizing of the system is built on several criteria. First of all, the size of
the chambers is linked to the quantity of drug that has to be injected and the
topology has to prevent from loss of drug. However, losses are unavoidable
and the topology has to permit a good filling of the chambers. A finite element
model was done to evaluate the influence of the geometry on the injected volume
and to the losses into the system.
The model was built using the COMSOL Multiphysics software. It consists
of a single chamber covered by a membrane. As the PDMS is a hyperelastic
polymer, the model cannot use standard solid mechanics model that does not
include large deformations. Therefore, the Neo Hookean model was chosen.
This model is an extension of Hooke’s law for the case of large deformations; it
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is useable for plastics and rubber-like substances. The model of neo-Hookean
solid assumes that the extra stresses due to deformation are proportional to
Finger tensor (1)
T = −pI+GB (1)
where T is the stress tensor, p the pressure, I the unity tensor, G a constant
equal to shear modulus, and B the Finger tensor. The strain energy for this
model is (2):
W =
1
2
GIB (2)
where W is potential energy and IB = tr(B) is the trace (or first invariant)
of Finger tensor B. The Neo-Hookean model only needs the shear modulus to
characterize the material since PDMS is supposed to be incompressible.
These computations were used as a tool to determine the influence of cham-
ber geometry on losses that have to be minimized and also to get an order of
magnitude of the required pressure to apply in order to obtain the expected
membrane displacement, which was found to be typically about one bar. At a
given pressure, there are two parameters that were considered to evaluate the
quality of the geometry: the displacement of the membrane and the ratio of
the remaining volume of the chamber divided by the volume occupied by the
deflected membrane (further noted Vi). This parameter has to be minimized
since it evaluates losses.
Cylindrical and squared chambers shape have been tested, and the ratio
was the same. As soon as a square shape leads to a better compaction, all
experiments were performed with this geometry.
As expected, increasing the shear modulus leads to a lower membrane de-
flection while the other parameters are set. Thus, these numerical simulations
give us orders of magnitude to set for the experiments in order to obtain the
required deflection. Therefore, in order to have the smallest Vi, we used the
lowest shear modulus (250 kPa) to evaluate the geometry efficiency. In the
same way, a thicker membrane has a lower deflection, and thicker chambers are
more difficult to empty. Therefor, after fixing a minimal thickness for the cham-
ber lateral walls (200 µm, due to the fabrication limits) all the surface of the
system is occuped by the chambers that are as thin and wide as possible. For
the prototype, in wich the needles are 1mm spaced, the chambers have a square
shape of 800 µm in side. The thicker these chambers are, the more product the
system can inject, but the dead volume goes higher to.
Furthermore, thanks to the model, we could obtain the evaluation of the
membrane deformation shape while it is under pressure. With these data, we
can adjust the height of steps, to manufacture a pyramidal like shape, done into
the chamber to reduce the dead volume (figure 6).
4.4 Results
On figure 7 the microfluidic system has been stuck on a hollowed micronee-
dle matrix. Figure 7.a shows the microneedle matrix before ejection, while the
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Figure 7: Above : microneedles before the ejection, and bottom : ejection of
ink through the needles
microfluidic system is already filled with a died liquid (ink). On Figure 7.b, ejec-
tion has been processed and the figure shows that all steps have been successfull
at 80 %: chambers filling and homogeneous ejection for the most importants.
This result shows that the microfluidic system successfully fulfils the following
requests: homogeneous injection of a liquid and control of the ejected volume
of each drop.
On figures 7, it is also noticeable that ink did not go through some of the
needles (20 %). These needles are probably clogged, and that may be caused by
several reasons: the needles may have not been completely pierced during the
fabrication or impurity may have obstructed the needles during the fabrication
process. There is also a possibility that the chambers above these needles were
not correctly filled; however, the good filling of the other chambers tend to refute
this hypothesis since a chamber which is not filled cannot fill next chambers since
they are connected via the filling circuit.
We can however verify that the ink passes through most of the needles and
that the ejected ink volume is almost the same for each needle (120 nl ± 10
nl). The control of the quantity and the homogeneity of ejection is therefore
achieved. Ejection test into the skin were not achieved until now while the
needles we used did not pierce the skin.
The main default of the system is that many and long fabrication stages are
required for a single use. It is therefore difficult to make a lot of assays with the
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system.
5 Conclusion
A microfluidic distribution system has been designed, fabricated and tested.
We successfully perform the manipulation of small liquid volumes (inital drop
of 20 µl) and further inject the liquid through a microneedle matrix with a
minimal loss of the drug (about 50% of the used drug). It provides a homogenous
injection over the entire matrix and allows controlling the quantity of drug that
is injected (120 nl ± 10 nl for each needle, i.e. a total injected volume about 10
µl).
More precisely, the system has been concieved to handle DNA solutions.
Now, making DNA pass through a microchannel is a method to obtain a random
fragmentation of it [10]. Therefore electrophoresis tests were done to verify the
integrity of DNA molecules after passing through the system. The asseys showed
that a 7kbp plasmide DNA did not fractionate in our conditions of use.
However, the manufacture of the whole system is a bit tricky. In particular,
the making of the diode require a manual operation witch is difficult at this
scale. Solutions remain to be found in order to make the realization of the sys-
tem easier and more repetitive.
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